16 Biotech Podcasts to Listen to in 2024

Last Updated on 

June 12, 2023

By 

Excedr
Animation of a sound wave turning into a listening ear
Table of Contents

Other Posts About Industry Insights

The biotech industry has undergone rapid growth and transformation over the last 10 years, resulting in significant advancements in drug discovery, genomics, gene editing, immunotherapy, oncology, and more.

Biotechnology podcasts have emerged as a powerful medium for professionals to stay informed about the latest developments and trends in this fast-moving industry.

Looking for a biotech podcast to listen to? We spoke with the Excedr team and our network of friends and colleagues to learn about which biotech podcasts they liked listening to the most!

Since we’re a lab equipment leasing company that primarily works with biotech companies and our team is pretty into podcasts (many of us hold science-related degrees as well), there were a lot of suggestions.

Instead of creating a massive and, perhaps, overly exhaustive list, we’ve whittled the suggestions down and created something quick and easy: a list of some of the best biotech podcasts to listen to. Consider it a starting point for your biotech podcast rolodex at the least.

Each podcast has demonstrated its value to us and many other listeners and can hopefully help you in different ways, from staying up-to-date and informed on the latest biotech trends and news in 2023 to learning how others have navigated a notoriously difficult yet exciting and constantly evolving industry.

Need new or refurbished lab equipment? Excedr leases.

See our equipment list and browse a sample selection of what we can source. Or, if you’re ready, request an estimate.

The Long Run

Launched in 2018, The Long Run is a biotech industry podcast hosted by Luke Timmerman, a veteran biotech journalist and founder of the Timmerman Report. The podcast has become one of the top-rated podcasts in the science and life sciences categories, and Timmerman’s in-depth biotech coverage continues to be an excellent resource for keeping up with the industry.

The show and blog cover a range of topics related to drug discovery and drug development, clinical trials, and other aspects of the biotech industry, such as biotech investment and artificial intelligence.

On the podcast, he interviews CEOs, other high-level executives, and investors in the industry, and his guests have included leaders from companies such as Alnylam Pharmaceuticals, Sanofi, Sage Therapeutics, Atlas Venture, Denali Therapeutics, ARCH Venture Partners, and much more.

Timmerman is known for his in-depth analysis and insightful commentary, and his interviews often provide listeners with a behind-the-scenes look at the challenges and opportunities facing the biotech industry. He also covers biotech news and trends, providing listeners with up-to-date information on the latest developments in the industry.

Episodes can be found on the Timmerman Report website, Apple Podcasts, and Soundcloud.

The Readout LOUD

The Readout LOUD is a podcast from STAT News, a leading health and science news outlet. The podcast is hosted by STAT News reporters and writers Damian Garde, Meg Tirrell, and Adam Feuerstein.

The podcast covers the latest news and trends in the biotech and pharmaceutical industries, with a focus on drug development, clinical trials, and so much more (e.g., cancer research, cell therapy, immuno-oncology, etc.). Each episode features in-depth discussions of the week’s top stories and interviews with industry insiders and experts.

The podcast started in 2017 and has become one of the most popular in the biotech and pharmaceutical industries. Episodes are typically released weekly and can be found on the STAT News website and Apple Podcasts, Spotify, and other podcast directories.

Tirrell, Garde, and Feuerstein are all experienced reporters with deep knowledge of the biotech and pharmaceutical industries. They bring a wealth of insights and analysis to each episode and are skilled at breaking down complex issues in a way that is accessible to listeners of all types

I AM BIO

Launched in 2019, I AM BIO is a podcast by the Biotechnology Industry Organization (BIO). The show explores the intersection of biotechnology and innovation and its societal impact. Rachel King, CEO of BIO, hosts the podcast.

The podcast covers a wide range of biotechnology and biopharma-related topics, including new innovations, breakthrough research, public policy, and industry trends.

Some recent episodes have focused on topics such as COVID-19 vaccine development, CRISPR, precision medicine, agricultural biotechnology, and the biotech industry’s role in addressing climate change.

The podcast is available on major podcast platforms like Apple Podcasts and Spotify, as well as on the BIO website. New episodes are released regularly.

The Biotech Startups Podcast

If you’re looking for an engaging biotech podcast that offers valuable insights into the industry, look no further than The Biotech Startups Podcast.

Hosted by Excedr’s CEO and co-founder, Jon Chee, our podcast provides listeners with a unique perspective on the biotech industry, with insights from first-time and serial entrepreneurs, experienced scientists and industry professionals, biotech investors, and more.

New episodes generally air every two weeks and can be found on all major podcast directories, including Apple Podcasts, Spotify, and Google Podcasts. Episodes can also be found on The Biotech Startups Podcast website.

In each episode, Jon Chee brings on guests like Jacob Glanville, founder, CEO, and president of Centivax, to talk about their career and journey in biotech. Through candid conversations and personal stories, listeners can gain actionable insights into navigating the ever-changing life sciences industry. Glanville covers his journey as an immuno-engineer working with antibodies.

What sets The Biotech Startups Podcast apart is its focus on exploring the business of life science, from pre-seed to IPO. In this sense, it’s all about building a biotech startup—understanding how much work goes into founding a company and overcoming the challenges the life sciences industry poses.

Listeners can expect to learn about industry trends, emerging technologies, and successful business strategies from unique perspectives. Whether you’re a graduate student, a postdoc, an aspiring entrepreneur, an experienced industry professional, or just interested in the biotech industry, this podcast has something for you.

Biotech2050

Biotech2050 is a “think tank chronicling the disruptions changing the biotech industry over the next 50 years.” It focuses on the future of the biotech industry.

The podcast was launched in 2020 and is hosted by Dr. Rahul Chaturvedi, the show’s co-founder. Chaturvedi is a seasoned biotech executive and entrepreneur with over two decades of experience in the biopharmaceutical industry.

He is also the CEO and co-founder of Clora, a tech platform solving the talent crisis across the life sciences industry, and Clonect Solutions, a regulatory compliance and technology consulting firm focused on the life sciences industry.

The podcast features interviews with industry professionals, thought leaders, innovators, and entrepreneurs driving the next generation of biotech innovations. Topics covered include biotech trends, emerging technologies, investment opportunities, and industry regulatory challenges.

The podcast can be found on major platforms, including Apple, Spotify, and Google Podcasts. New podcast episodes are typically released around once a week.

The Bio Report

The Bio Report podcast explores the intersection of biotechnology with business, science, and policy. It is hosted by Daniel Levine, a veteran journalist who has covered the biotech industry for over 20 years.

Launched in 2013, the show features interviews with biotech entrepreneurs, executives, researchers, and investors, covering a wide range of topics, including drug development, healthcare policy, clinical trials, and R&D financing.

It also includes news analysis, company profiles, and discussions of current events in the biotech industry.

New episodes are typically released weekly and can be found on major podcast platforms such as Apple, Spotify, and Google Podcasts. The Bio Report also has a website where listeners can find more information about each episode and listen to the podcast directly from the website.

First In Human

Started in 2022, First In Human is a biotech podcast by Vial, a Contract Research Organization (CRO) specializing in clinical trial management. The podcast focuses on innovations in clinical research, clinical trials, strategies for treating rare diseases, and emerging therapies.

It features discussions with various industry experts and investors who share their insights and experiences on studying the efficacy and safety of drugs, securing regulatory approval, and generally navigating the world of biotech.

The podcast is hosted by a team of Vial employees and experts who engage guests in conversations about current events, upcoming research, and breaking news related to the biotech industry.

New episodes air weekly on Tuesdays, with a different guest interviewed each time. The podcast is available on Vial’s website and other major platforms such as Apple, Spotify, and Google Podcasts.

The podcast is known for its engaging and informative content, with many listeners citing it as a valuable resource for learning about the journey to in-human clinical trials. The show’s diverse range of guests and topics make for a captivating and insightful listening experience.

BioTalk

Started in 2017, Biotalk with Rich Bendis aims to provide listeners with insights into the latest trends and developments in biotechnology and life sciences trends and developments and showcase different ways they can grow their businesses.

It’s hosted by Rich Bendis, an entrepreneur, corporate executive, venture capitalist, and investment banker with over 30 years of experience in the life sciences industry.

He is the president and CEO of BioHealth Innovation, Inc. (BHI), a non-profit organization that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in Maryland.

The podcast features interviews with industry leaders, entrepreneurs, scientists, and investors who share their experiences and perspectives on various topics, including biotech startups, venture capital, drug development, medical devices, and healthcare policy.

New Biotalk episodes generally air weekly, and the podcast is available on popular platforms like Apple, Spotify, and Google Podcasts.

Talking Biotech

Talking Biotech is a weekly podcast hosted by Dr. Kevin Folta, a professor in the Horticultural Sciences Department at the University of Florida. It’s produced by Colabra, an R&D workflow visibility platform.

The podcast explores the stories, ideas, and research of individuals at the forefront of biology and engineering, focusing on how science and technology can transform agriculture, protect the environment, and feed the world’s growing population.

Topics covered include genetic engineering, mRNA and RNA, crop improvement, sustainable agriculture, and the intersection of science and society.

Dr. Folta interviews a diverse range of guests, including scientists, entrepreneurs, policymakers, and farmers, to provide a broad perspective on the latest developments in biotechnology.

The podcast was launched in 2015 and has since released more than 300 episodes, making it one of the longest-running podcasts in the biotech space. It’s available on major podcast platforms like Apple, Spotify, and Google Podcasts, as well as on the Talking Biotech website.

Beyond Biotech

Beyond Biotech is a weekly podcast presented by Labiotech, a leading European digital media platform covering the biopharma and biotech industry.

Hosted by Jim Cornall, an experienced journalist specializing in biotech and life sciences, the podcast focuses on the latest news and trends in the biotech industry, with each episode featuring discussions with industry insiders, experts, and thought leaders.

Topics covered in the podcast include the latest on clinical studies, biotech investments, collaborations, new technologies in the biotech industry, and more.

In addition to its regular episodes, Beyond Biotech also features themed episodes. These special episodes invite experts in the field to raise awareness and discuss global issues related to biotech.

The podcast was started in 2022 and has been releasing weekly episodes ever since. It’s available on major podcast platforms, including Apple, Spotify, and Google Podcasts.

Beyond Biotech has been praised for its insightful and engaging content, with listeners seeing it as a valuable resource for keeping up with the latest developments in the biotech industry.

Hopkins Biotech Podcast

Airing since 2020, the Hopkins Biotech Podcast focuses on the latest news and trends in biotechnology, with a particular emphasis on entrepreneurship and the industry’s commercialization. New episodes are generally released twice a month.

In each episode, the hosts interview entrepreneurs, investors, and scientists in the biotech industry, with discussions often covering topics like industry innovation, startup creation, drug development, and regulatory issues. In addition to its regular episodes, the show also features episodes that provide insights into the biotech industry’s careers and job opportunities.

The Hopkins Biotech Podcast is hosted by Joe Varriale, Jenna Glatzer, and Gustavo E. Carrizo, graduate students at the Johns Hopkins University School of Medicine.

The podcast is available on major platforms, including Apple Podcasts and Spotify. Episodes can also be found on the Hopkins Biotech Podcast website.

Business of Biotech

The Business of Biotech is hosted by Matt Pillar, the Chief Editor of BioProcess Online, which provides information on the biotech industry.

The podcast focuses primarily on the latest news, trends, and insights related to running a biotechnology company and is considered an excellent resource for anyone generally interested in the biotech industry.

The Business of Biotech regularly features interviews with industry professionals, thought leaders, and executives from top biotech companies, who typically discuss a wide range of topics, from drug development, commercialization, regulatory issues, funding, and much more.

Guests share their experiences and insights on various aspects of the biotech industry and offer valuable advice for entrepreneurs, investors, and professionals.

The Business of Biotech is available on major podcast directories such as Apple, Spotify, and Google Podcasts and has received positive reviews from listeners for its informative and engaging content.

Axial

The Axial Podcast is hosted by Joshua Elkington, a biotech industry professional with years of experience working in various roles across the biotech and pharmaceutical sectors. The show features conversations with a wide range of scientists, founders, CEOs, and VC investors working in biotech and biopharma.

It’s presented by Axial VC, a venture capital firm that partners with founders and inventors building early-stage life science companies.

The podcast aims to educate listeners about the latest trends and innovations in the biotech industry, and to provide valuable insights into the challenges and opportunities facing biotech companies and investors today.

It has been airing since 2021 and does not have a specific schedule for publishing new episodes. However, there tend to be a few published each month. Episodes can be found on Apple Podcasts, Spotify, Substack, and other platforms.

Biotech Hangout

Biotech Hangout is a weekly podcast focusing on breaking news, data, deals, and FDA actions in the biotech industry. The podcast is hosted by Daphne Zohar, the founder and CEO of PureTech Health, and Josh Schimmer, managing director at Evercore ISI.

It also often features other regular co-hosts, including Bruce Booth, Atlas Ventures partner, Dawn Bell, Global Development Head of Strategic Partnerships at Novartis, and Michal Preminger, Regional Head of East North America for J&J Innovation.

In each episode, Zohar and Schimmer discuss the latest developments in the biotech industry and provide insights into the implications for investors, entrepreneurs, and other stakeholders.

They also interview a wide range of guests, including industry executives, scientists, investors, and policymakers, to provide a diverse perspective on the latest trends and issues in the biotech space.

The podcast was launched in 2021 and has since released dozens of episodes, making it a relatively new entrant to the biotech podcast scene. It can be found on all major podcast directories, including Apple, Spotify, and Google Podcasts, as well as on the Biotech Hangout website.

Between the Biotech Waves

Between the Biotech Waves is hosted by Nessan Bermingham, a biotech entrepreneur and investor. The podcast aims to provide insights and analysis on the latest trends and news in the biotech industry and to feature conversations with experts, executives, and investors in the field.

Since its debut in 2022, the podcast has covered many topics, from new drug approvals and clinical trials to regulatory changes and market trends. Recent episodes include discussions on gene therapies, vaccine development, cancer immunotherapy, and the impact of digital health technologies on the industry.

Bermingham has a Ph.D. in molecular genetics and has co-founded several biotech companies, including Triplet Therapeutics, Intellia Therapeutics, and BlueRock Therapeutics. He also serves as an operating partner at Khosla Ventures.

The show’s guests come from a variety of backgrounds, including academia, biotech startups, pharmaceutical companies, and investment firms.

Listeners can expect to gain valuable insights into the latest developments and market dynamics in the biotech sector and hear firsthand accounts from industry leaders on their experiences and strategies for success. Episodes are available on most major podcast directories, including Apple Podcasts and Spotify.

The Top Line by Fierce Biotech

The Top Line is hosted by a group of journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma and is produced by Fierce Life Sciences, a leading news outlet that covers the biotech industry.

The podcast covers the latest news and trends in the biotech industry, with a focus on the most important business news of the week, from mergers and marketing to drug development, device development, and innovation. Each episode features in-depth discussions of the week’s top stories and interviews with industry insiders and experts.

New episodes are released weekly on Fridays and can be found on the Fierce Biotech website, Apple Podcasts, Spotify, and other podcast platforms.

The Top Line is an excellent resource for staying up-to-date with the latest news and trends in biotechnology and the life sciences.

Podcasts Can Help You Keep Up with Biotech & the Life Sciences

Biotech podcasts are an excellent resource for anyone looking to keep up with the latest developments in the industry.

Shows typically offer valuable insights from industry leaders, experts, and experienced professionals, covering various topics, from science and technology to entrepreneurship and investment. Whether you’re a scientist, entrepreneur, investor, or just interested in the field, there’s a biotech podcast for you.

And, if you’re looking for a new podcast to add to your list, check out The Biotech Startups Podcast, our very own podcast that we launched in March 2023.

Hosted by Jon Chee, Excedr’s co-founder and CEO, this podcast offers a unique perspective on the biotech industry, with insights from experienced industry professionals, including founders, scientists, and company operators.

Please tune in to learn more about navigating the world of biotechnology and gain valuable insights into what it takes to build a biotech startup in a rapidly evolving field.

If you’re interested in equipment leasing for your biotech company, let us know. We’re a scientific equipment leasing company with over a decade of experience leasing to biotechs large and small.

Other Posts About Industry Insights